Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer.
| Autor: | Zeng, C1, Vangveravong, S1, McDunn, J E2, Hawkins, W G3, Mach, R H4 |
|---|---|
| Zdroj: | British Journal of Cancer. 10/29/2013, Vol. 109 Issue 9, p2368-2377. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|